BACKGROUND Company: Mid-sized pharmaceutical company Indication: Advanced unresectable dedifferentiated liposarcoma Phases: II and III (sequential studies) CHALLENGE The sponsor needed to incorporate multiple tumor assessment criteria (RECIST, CHOI, WHO, PERCIST) into the image evaluation protocol (IEP), which significantly increased image reading complexity, turnaround time and cost challenges. They chose to use ERT’s purpose-built oncology image processing and analysis technology for software-guided radiologist reads, including automated evaluation of lesion metrics and response per multiple tumor assessment criteria for baseline and post-therapy follow-up computed tomography (CT) or magnetic resonance imaging (MRI) exams. BASELINE CT SCAN The software also provides guided, semi-

Join for free to read